Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Vivjan Myrto - aVenture Research

Vivjan Myrto

AddedMar 31, 2024

UpdatedOct 18, 2026

Vivjan Myrto

Vivjan Myrto

Co-Founder, Hyperplane

Vivjan Myrto's Career

Biobot Analytics

Vivjan Myrto's Co-Investors

Walter WinshallCo-invested · Indico Data Seed

Simeon SimeonovCo-invested · Indico Data Seed

Yuchun LeeCo-invested · Indico Data Seed

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Vivjan Myrto's Investments

1 investments since 2014

1 operating

Investments view

Group by

2014

1

Indico Data
Seed · November 2014$3M
Seed · November 2014

Series B$41.4MCambridge, MA, US

Board Observer

Hyperplane

Investment FirmBoston, MA, US

Co-Founder

Green Eye Technology

Series A$31MTel Aviv, Tel Aviv District, IL

Board Member· Board

Dexai Robotics

Series A$12.2MSomerville, MA, US

Board Member· Board

ShipIn

Series A$24MNewton, MA, US

Board Member· Board

Elucidata

Series A$23.6MCambridge, MA, US

Board Member· Board

Matt MalloyCo-invested · Indico Data Seed

Ty DancoCo-invested · Indico Data Seed

Paul SaganCo-invested · Indico Data Seed

Michael MarkCo-invested · Indico Data Seed

People Similar to Vivjan Myrto

Michael MarksBoard Member · Globant

Matt OckoBoard Member · Rocket Lab

Nan LiCo-Founder · Dimension

John GiannuzziBoard Member · Boathouse Sports

Recent news

Findings from Biobot's Nationwide Wastewater Monitoring Program for Prescription and High-Risk Substances Published in Nature WaterMorningstar (PR Newswire) · 2026

Biobot Analytics Selected by White House Office of National Drug Control Policy to Provide Nationwide Wastewater Intelligence on Substance Use TrendsPR Newswire · 2026

Biobot readies for expansion into new marketsCambridge Day · 2025

Leadership at Biobot Analytics

Andrew PerlmanBoard Director

Newsha GhaeliPresident & Co-Founder

Vivek PattipatiBoard Director

Similar to Biobot Analytics

KandoTsur Yigal, ILest. 2014KandoTsur Yigal, IL · est. 2014

Kando is a wastewater intelligence company turning sewer network sensor data into real-time operational and public-health insights.

VerilySouth San Francisco, CA, USBiotechnology, Healthcareest. 2015VerilySouth San Francisco, CA, US · est. 2015

Recent news

Voice AI startup Modulate raises $25M to bring audio-native models to more developersSiliconAngle · 2026

Modulate raises $25M for its voice models and analysis suiteTechCrunch · 2026

Leadership at Hyperplane

John MurphyCo-Founder

Brendan KohlerCo-Founder

Similar to Hyperplane

Hyperwise VenturesTel Aviv, Tel Aviv District, ILest. 2020Hyperwise VenturesTel Aviv, Tel Aviv District, IL · est. 2020

Venture capital firm merging groundbreaking technology with strategic business execution.

Investment Firm5

Leadership at Green Eye Technology

Nadav BocherCo-Founder

Alon Klein OrbakCo-Founder

Itzhak KhaitCo-Founder

Similar to Green Eye Technology

EcoPesticidesAlbuquerque, NM, USPesticidesest. 2012EcoPesticidesAlbuquerque, NM, US · est. 2012

EcoPesticides: Pioneering green pesticide technology for sustainable, effective pest solutions.

Series A · $400k6

GenZ TechnologyBoise, ID, USSpray Technologyest. 2011GenZ TechnologyBoise, ID, US · est. 2011

GenZ Technology: Superior, eco-friendly agricultural spray tech boosting productivity since 2011.

Series A · $1.6M6

Organicin ScientificAmherst, MA, USBiopesticidesest. 2018Organicin ScientificAmherst, MA, US · est. 2018

Organicin Scientific: Enhancing crop yield and profitability with sustainable biopesticide solutions.

Angel · $120k2

Crop EnhancementSan Jose, CA, USCrop Protectionest. 2011Crop EnhancementSan Jose, CA, US · est. 2011

Crop Enhancement: Boosting crop yields with sustainable, eco-friendly agrochemical solutions.

Series B · $16.5M31

Leadership at Dexai Robotics

Anthony TayounCo-Founder

David JohnsonCo-Founder & CEO

Similar to Dexai Robotics

Chef RoboticsSan Francisco, CA, USFood Automationest. 2019Chef RoboticsSan Francisco, CA, US · est. 2019

Chef Robotics: Revolutionizing the food industry with AI and robotics to combat labor shortages globally.

Series A · $22.5M36

EatXNew York City, NY, USKitchen Automationest. 2021EatXNew York City, NY, US · est. 2021

Revolutionizing kitchens with a data-driven automation platform using computer vision and robotics.

Pre-Seed · $100k8

Nala RoboticsArlington Heights, IL, USCloud Kitchen, Robot Chefsest. 2017Nala RoboticsArlington Heights, IL, US · est. 2017

Nala Robotics: An AI tech firm revolutionizing the culinary industry with automated, multi-cuisine robot chefs and a cloud-based kitchen platform.

Pre-Seed · $1.9M194

BlendidSunnyvale, CA, USFood Service, Roboticsest. 2015BlendidSunnyvale, CA, US · est. 2015

Blendid: Pioneering autonomous food kiosks with AI-enabled robotic solutions.

Series A · $20.3M42

Leadership at ShipIn

Osher PerryCo-Founder

Ilan NaslavskyCo-Founder

Similar to ShipIn

Captain's EyeHaifa, Haifa District, ILVessel Safetyest. 2020Captain's EyeHaifa, Haifa District, IL · est. 2020

Captain's Eye enhances maritime safety and reduces pollution risks through machine vision analytics.

Series A · $4.1M8

Voyager PortalHouston, TX, USAnalytics Platformest. 2018Voyager PortalHouston, TX, US · est. 2018

Voyager Portal: A unified platform for maritime operations, enhancing efficiency and reducing costs through automation and real-time insights.

Series A · $10.2M46

ioCurrentsSeattle, WA, USData Analyticsest. 2015ioCurrentsSeattle, WA, US · est. 2015

ioCurrents: Transforming maritime sensor data into actionable intelligence online.

Series A · $6.3M14

AI FleetAustin, TX, USFleet Managementest. 2020AI FleetAustin, TX, US · est. 2020

aifleet: A driver-centric trucking firm offering AI fleet management solutions.

Series B · $39.1M175

Leadership at Elucidata

Swetabh PathakCo-Founder

Abhishek JhaCo-Founder

Richard KibbeyBoard Member

Parul Budhraja KhannaCo-Founder

Dr Robert R Ruffolo Jr "Bob"Board Member

Similar to Elucidata

OwkinNew York City, NY, USAI Drug Discovery, Diagnosticsest. 2016OwkinNew York City, NY, US · est. 2016

NYC-based Owkin, Inc. leverages machine learning for predictive analytics in biotech, serving global pharma.

Series B · $304.1M441

Mariana MatusFounder

John McIntyreBoard Member

Verily Life Sciences, an Alphabet Inc. subsidiary, is dedicated to life sciences research.

Public · $3.5B2k

Stanford UniversityStanford, CA, USEducation, Researchest. 1891Stanford UniversityStanford, CA, US · est. 1891

Stanford University: A prestigious private research institution in California, educating over 17,000 students.

Biota TechnologySan Diego, CA, USData Analyticsest. 2013Biota TechnologySan Diego, CA, US · est. 2013

Biota: Pioneering biosurveillance through DNA sequencing and data science for energy sectors.

HypothesisWillow Grove, PA, USest. 2020

HypothesisWillow Grove, PA, US · est. 2020

Hypothesis: A venture capital firm partnering with tech entrepreneurs across the U.S, fostering innovation beyond the Bay Area.

Investment Firm24

AisproutsMenlo Park, CA, USest. 2019AisproutsMenlo Park, CA, US · est. 2019

An AI and cloud service provider, fueling innovation through bold entrepreneurial pursuits.

Investment Firm2

futurelandWashington, D.C., DC, USest. 2021futurelandWashington, D.C., DC, US · est. 2021

Venture capital syndicate investing in early-stage tech startups for a sustainable, connected future.

Investment Firm6

PostEraBoston, MA, USDrug Discoveryest. 2019

PostEraBoston, MA, US · est. 2019

PostEra: ML-driven drug discovery, advancing medicinal chemistry with top biopharma partnerships.

Series A · $26.3M34

ConcertAICambridge, MA, USData Analytics, Medical Researchest. 2018ConcertAICambridge, MA, US · est. 2018

ConcertAI: Leveraging AI and real-world data for innovative oncology research and care solutions.

Series C · $300M3k

Seismic TherapeuticWatertown, MA, USBiologics, Drug Discoveryest. 2020Seismic TherapeuticWatertown, MA, US · est. 2020

Seismic Therapeutic: A biotech firm using machine learning to expedite immunology drug development.

Series B · $222M58